Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
Dow 11,913.60 +104.83 0.89%
S&P; 500 1,254.19 +15.94 1.29%
Nasdaq 2,699.44 +61.98 2.35%
Ticker Volume Price Price Delta
STOXX 50 2,369.07 +31.56 1.35%
FTSE 100 5,548.06 +59.41 1.08%
DAX 6,055.27 +84.31 1.41%
Ticker Volume Price Price Delta
Nikkei 8,819.94 -24.04 -0.27%
TOPIX 751.71 -3.73 -0.49%
Hang Seng 18,910.80 +139.02 0.74%
Gold 1,651.40 -0.05%
EUR : USD 1.3908 -0.1518%
Nasdaq 2,699.44 +2.35%
Dow 11,913.60 +0.89%
S&P; 500 1,254.19 +1.29%
FTSE 100 5,548.06 +1.08%
STOXX 50 2,369.07 +1.35%
DAX 6,055.27 +1.41%
Oil (WTI) 91.33 +0.07%
U.S. 10-year 2.222% +0.003
8918:JP 26.00 -3.70%
7733:JP 1,165.00 +6.01%

U.S. News

  • Euro Snap Four-Day Rally After Europe Summit

    Stocks surged, almost erasing the 2011 loss in the Standard & Poor’s 500 Index, as Europe made progress in debt-crisis talks, Caterpillar Inc.’s earnings beat forecasts and takeovers lifted health-insurance and software companies. Commodities rose on signs of Asian growth.

  • Texas Instruments’ Fourth-Quarter Forecast Misses

    Texas Instruments Inc., the largest maker of analog semiconductors, forecast lower fourth-quarter sales than some analysts had estimated, indicating that demand for electronic components remains sluggish.

  • Netflix

    Netflix Inc., the video-rental service, posted third-quarter customer losses that were worse than its September forecast and predicted more cancellations over a price hike. The shares plunged 27 percent.

  • Amgen Inc., the world’s largest biotechnology company, said it set aside $780 million to resolve civil and criminal investigations into whether it engaged in improper sales of drugs, including its Aranesp anemia medicine.

Advertisement
Sponsored Links
Advertisement
Advertisements